Human Genome Sciences

Sector:
Healthcare

Location:
Rockville, MD

Year Funded:
1993

Status:
IPO

Website:
www.hgsi.com


Summary:
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat lupus, hepatitis C, inhalation anthrax and cancer.